48,830
edits
Difference between revisions of "Intraductal carcinoma of the prostate"
Jump to navigation
Jump to search
Intraductal carcinoma of the prostate (view source)
Revision as of 19:06, 13 April 2018
, 19:06, 13 April 2018→Prevalence
(→General: +prevalence) |
|||
| Line 48: | Line 48: | ||
! Prevalence | ! Prevalence | ||
|- | |- | ||
| | | WHO1† | ||
| 2% | | 2% | ||
|- | |- | ||
| | | WHO2† or WHO3† | ||
| 23% | | 23% | ||
|- | |- | ||
| | | WHO4† or WHO5† | ||
| 37% | | 37% | ||
|- | |- | ||
| | | Metastasis or recurrence | ||
| 56% | | 56% | ||
|} | |} | ||
† WHO1 = WHO grade group 1 (Gleason score 6), WHO2 = WHO grade group 2 or 3 (Gleason score 7 (3+4 or 4+3), WHO3 = WHO grade group 4 or 5 (Gleason score 8, 9 or 10) | |||
==Microscopic== | ==Microscopic== | ||